Spire Healthcare Group (LON:SPI) Trading 14.1% Higher - What's Next?

Key Points

• Spire Healthcare Group's shares rose by 14.1%, closing at GBX 247 ($3.33) after trading as high as GBX 256.50 ($3.46), with trading volume increasing to nearly 10 million shares.
• Analyst ratings show a consensus of "Buy" for Spire Healthcare, with price targets ranging from GBX 280 to GBX 294.33.
• The company reported GBX 4.10 earnings per share for the latest quarter, with a projected annual EPS of approximately 15.66 for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares were up 14.1% on Saturday . The company traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). Approximately 9,747,062 shares were traded during trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on SPI shares. Berenberg Bank reissued a "buy" rating and set a GBX 280 target price on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. dropped their target price on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of GBX 294.33.

Spire Healthcare Group Stock Performance

The firm has a market cap of £947.58 million, a price-to-earnings ratio of 5,119.57, a P/E/G ratio of 1.06 and a beta of 0.96. The stock has a 50 day moving average of GBX 218.75 and a 200 day moving average of GBX 203.55. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, analysts anticipate that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.